Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Chimeric antigen receptor immune cell provided with safety switch as well as preparation method and application of chimeric antigen receptor immune cell

A chimeric antigen receptor and safety switch technology, applied in the field of biomedicine, can solve problems such as cell mutation and canceration

Inactive Publication Date: 2017-05-31
AFFILIATED HOSPITAL CHINA ACADEMY OF MILITARY MEDICAL SCI +1
View PDF3 Cites 24 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] Although CAR-T technology has been proven to be highly effective by most domestic and foreign preliminary clinical studies, it is similar to the conventional lymphoma / leukemia radiotherapy and chemotherapy treatment process, and the side effects are still not to be underestimated; Similar to the treatment, the application of CAR-T cells needs to be combined with cytokines and other related treatments, such as chills, fever, leukopenia, tumor lysis syndrome, cytokine storm, hypoimmunoglobulinemia caused by B cell deficiency, etc. It is a common adverse reaction; in addition, the integration of foreign genes also has the risk of causing cell mutation or even cancer

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Chimeric antigen receptor immune cell provided with safety switch as well as preparation method and application of chimeric antigen receptor immune cell
  • Chimeric antigen receptor immune cell provided with safety switch as well as preparation method and application of chimeric antigen receptor immune cell
  • Chimeric antigen receptor immune cell provided with safety switch as well as preparation method and application of chimeric antigen receptor immune cell

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0051] Example 1: Synthesis of CAR expression cassette and construction of expression vector

[0052]According to the amino acid sequence and coding sequence of each component of CAR, splicing into the entire fused amino acid sequence and coding DNA expression cassette, the full-length sequence contains anti-hCD20scFv (SEQ ID NO: 2 or SEQ ID NO: 6) and human CD28 Transmembrane and intracellular segment (SEQ ID NO:3 or SEQ ID NO:7), CD3ζ chain (SEQ ID NO:4 or SEQ ID NO:8) and HSVTK suicide gene (SEQ ID NO:5 or SEQ ID NO:9 ), collectively referred to as anti-hCD20scFv-CD28z-CD3ζ-HSVTK sequence (such as figure 1 shown), the two ends of the sequence introduced the coding sequence of XbaI and SalI restriction endonuclease cutting sites. In the present invention, the full-length sequence of anti-hCD20scFv-CD28z-CD3ζ-HSVTK is artificially synthesized, and BGI Gene Co., Ltd. is commissioned to synthesize it for a fee. The third-generation lentiviral vector pLenti-CMV is selected, an...

Embodiment 2

[0054] Example 2: Viral packaging comprising a CAR structure

[0055] Use 293FT as packaging cells, and when they reach 90% confluence, replace with serum-free DMEM medium, and use Lipofectamine3000 as the transfection reagent. For a six-well plate, the amount of plasmids used for transfection is respectively, vsv-G0.37μg +tat 0.19μg+rev 0.19μg+gag 0.19μg+vector(pLenti-CMV-anti-hCD20scFv-CD28z-CD3ζ-HSVTK) 2μg, operate according to the instructions of Lipofectamine3000, after preparing the transfection solution, add it to the serum-free medium for culture In the 293FT, after 6 hours, replace it with 10% fetal bovine serum DMEM complete medium, continue to culture for 48-72 hours, collect the virus liquid, filter and centrifuge at 90,000gx for 2 hours, add 500μl PBS / tube, and freeze in - Standby at 80°C.

Embodiment 3

[0056] Example 3: Preparation of anti-hCD20-CAR-T (CAR20-T)

[0057] Using a 50ml syringe, collect 50ml of peripheral blood from a lymphoma patient at one time, dilute it with PBS at a rate of 1:2, and slowly add it to the Ficoll separation solution at a ratio of 2:1. Centrifuge at 1500rpm for 10 minutes at room temperature, it can be seen that it is divided into three layers, and the white layer in the middle is lymphocytes; gently suck the lymphocyte layer into 6ml~8mlRPMI1640 to elute; centrifuge at 1500rpm for 10 minutes; remove the supernatant, add 2mlRPMI1640, and count Press 0.5x 10 6 / ml added to OpTmizer TM In T-cell Expansion SFM medium, cultivate overnight. Mix the virus liquid obtained in the previous step with MOI 5, polybrene 10 μg / ml / , 1000 IU / ml recombinant human interleukin 2 (rhIL-2) and add it to T cells after overnight culture, the cell concentration is 0.5×10 6 / ml, after culturing overnight, replace with OpTmizer containing 1000IU / ml rhIL-2 TM T-cell ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a chimeric antigen receptor (CAR) immune cell provided with a safety switch as well as a preparation method and an application of the CAR immune cell. The CAR immune cell carrying the safety mechanism (the safety switch) comprises a CAR coding nucleotide sequence, wherein the structure of the nucleotide sequence comprises a receptor structural domain for recognizing tumor-specific antigen or tumor-associated antigen, a transmembrane-stimulation structural domain, a CD3[zeta] stimulating signal transduction region and a suicide gene region. The CAR immune cell can be obtained as different immunological effect cells are amplified and a CAR sequence carrying a suicide mechanism is transduced; corresponding antigens of tumor cells are recognized by virtue of CAR; and the CAR immune cell can generate a specific killing effect on the tumor cells. The CAR immune cell, when used, is infused in a gradient mode and dynamic change in related cell factor levels is monitored; in case of need, a suicide gene can be started by virtue of drugs to scavenge the immunological effect cells, so that optimal balance between safety and a curative effect is achieved; therefore, the safety of the technology applied to the treatment of tumors in the clinical field is guaranteed to the greatest extent.

Description

technical field [0001] The present invention relates to the field of biomedicine, in particular to the main structure of a gene-modified chimeric antigen receptor (CAR) immune effector cell carrying a safety mechanism, its preparation method and application. The nucleic acid sequence of the CAR cell carrying a safety mechanism encodes a CAR with a safety switch, and the nucleic acid sequence structure includes a chimeric antigen receptor domain that recognizes a tumor-specific antigen or a tumor-associated antigen, a transmembrane-stimulatory domain, and a CD3ζ Stimulates signal transduction regions, integrated suicide gene regions. Background technique [0002] Surgery, radiotherapy, chemotherapy, and palliative care, as the traditional treatment methods for malignant tumors, have always occupied a dominant position in anti-tumor therapy. In the past ten years, with the continuous deepening of the research on the internal mechanism of tumor development and its external mic...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N15/62C12N5/10A61K48/00A61K35/17A61P35/00A61P35/02
Inventor 袁顺宗刘兵苏航李庆虹孙磊廖辉阳
Owner AFFILIATED HOSPITAL CHINA ACADEMY OF MILITARY MEDICAL SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com